SynCore Biotechnology Co (ROCO:4192) 3-Year EBITDA Growth Rate : 64.10% (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is SynCore Biotechnology Co 3-Year EBITDA Growth Rate?

SynCore Biotechnology Co's EBITDA per Share for the three months ended in Dec. 2023 was NT$1.31.

During the past 3 years, the average EBITDA Per Share Growth Rate was 64.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 41.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 13.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of SynCore Biotechnology Co was 64.10% per year. The lowest was -28.70% per year. And the median was -3.10% per year.

Competitive Comparison of SynCore Biotechnology Co's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, SynCore Biotechnology Co's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SynCore Biotechnology Co's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SynCore Biotechnology Co's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where SynCore Biotechnology Co's 3-Year EBITDA Growth Rate falls into.

SynCore Biotechnology Co 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

SynCore Biotechnology Co (ROCO:4192) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

SynCore Biotechnology Co 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of SynCore Biotechnology Co's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

SynCore Biotechnology Co (ROCO:4192) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SynCore Biotechnology Co Ltd (ROCO:4192) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.84 Zhongshan Road, Zhongshan Village, Dongshan Township, Yilan, TWN, 269

Website

https://www.syncorebio.com

SynCore Biotechnology Co Ltd is a biopharmaceutical company. Its pipeline products concentrate on the ophthalmology, oncology, and dermatology fields. The pipeline products of the company include SB01 and 02, SB03, SB04, and SB05. It is engaged in drug development and sale, food advisory, medicine inspection, biotechnology service and intellectual property. It operates in a single industry, the new drug development.

SynCore Biotechnology Co (ROCO:4192) Headlines

No Headlines